echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Six pharmaceutical associations jointly wrote to the medical reform office of the State Council and relevant ministries and commissions, proposing to modify and improve the "two envelope" system of bidding for essential drugs

    Six pharmaceutical associations jointly wrote to the medical reform office of the State Council and relevant ministries and commissions, proposing to modify and improve the "two envelope" system of bidding for essential drugs

    • Last Update: 2011-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Recently, media reported that in order to occupy the grass-roots medical market, some pharmaceutical manufacturers adopted the strategy of "winning the bid at a low price" In actual production, in order to reduce production costs, they violated GMP Standardizing, secretly reducing the quality of products, cutting down the materials, even adulterating and making false, has caused a great threat to the people's life and health, also disrupted the order of the medical market, and affected the smooth implementation of the medical reform To this end, recently, six pharmaceutical industry associations, including China Pharmaceutical Industry Research and Development Promotion Association, China Pharmaceutical Enterprise Management Association, China Chemical Pharmaceutical Industry Association, China traditional Chinese Medicine Association, China Pharmaceutical Quality Management Association, and China over the counter drug association, jointly wrote to the office of the leading group for medical reform under the State Council, the national development and Reform Commission, the Ministry of industry and information technology, and the Ministry of health The disadvantages and harms of the regulations of "winning the bid at the lowest price" in the bidding and purchasing system of essential drugs are pointed out, and suggestions are put forward to modify and perfect the "two envelope" system in the bidding and purchasing system of essential drugs This is the continuation of the "Symposium on improving the bidding and purchasing system of essential drugs" held in Beijing by some enterprises and media representatives invited by the association on May 24 According to the proposal, the current bidding and purchasing system for essential drugs and the implementation of the "two envelope" system in the bidding for essential drugs are reasonable However, there are some urgent needs to be improved in the practical implementation of the "two envelope" system: on the one hand, the drug quality threshold in the economic and technical bids in the "two envelope" system is too low, which is just a formality; on the other hand, the provisions and practices of the evaluation of commercial bids by the lowest bidder are inconsistent with the policy requirements of "quality first, reasonable price", which may lead to the reduction of drugs Quality even threatens people's drug safety Therefore, the six associations put forward the following four suggestions: first, economic and technical bids should give full play to the role of the quality threshold of essential drugs, change the practice of only pursuing "quality qualified", and truly reflect the principle of "quality first" It is suggested that the state should establish a unified and quantifiable comprehensive evaluation index system for basic drug manufacturers to ensure that only those pharmaceutical enterprises with good faith, standard quality, strength and sense of social responsibility can enter the scope of bidding and purchasing of basic drugs Second, bring the scores of economic and technical bids of the enterprises participating in the bidding into the evaluation of commercial bids, and make them occupy a larger weight, and finally select the winning enterprises through comprehensive scores; enterprises manufacturing and selling fake and inferior drugs are all prohibited from entering the market of essential drugs Thirdly, on the basis of establishing a perfect drug market price monitoring system and reflecting the advanced cost of society, the middle price method is used to determine the reasonable base price of basic drugs The relevant departments of the State shall investigate and calculate the industry average cost of essential drugs, and gradually establish a dynamic monitoring system for the production cost of essential drugs; for the typical products that are confirmed to be lower than the cost through investigation and win the bid, the bid shall be annulled and the enterprise bidding shall be reorganized Fourth, we should conduct classified bidding procurement according to different situations, such as exclusive varieties, special drugs, commonly used short and cheap drugs, and basic drugs with basically stable prices For the varieties with retail guide price lower than 10 yuan issued by national development and Reform Commission, only enterprises are invited but not prices The proposal also pointed out that attention should not only be paid to the price of essential drugs, but also to the quality assurance, safety and accessibility of drugs The development of medicine industry and the development of health service in China are complementary In the process of implementing and adjusting the bidding and purchasing policies for essential drugs, the relevant departments should respect the market laws and the development laws of the pharmaceutical industry, listen to the opinions of all parties and make prudent decisions, strive to promote social development, practically solve the problems of people's livelihood, and promote the economic and social development to the track of scientific development.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.